HIPK4 accelerates cutaneous squamous cell carcinoma progression by phosphorylating TAp63 and inhibiting EFEMP1

Ze Guo1, Bingjie Chen1, Mengya Zhang1

  • 1Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, P.R. China.

Insights

Homeodomain interacting protein kinase 4 (HIPK4) drives cutaneous squamous cell carcinoma (CSCC) progression by inhibiting EFEMP1 via TAp63 phosphorylation. Targeting HIPK4 may offer a new therapeutic strategy for CSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Cutaneous squamous cell carcinoma (CSCC) is a prevalent skin cancer with metastatic potential.
  • Homeodomain interacting protein kinase 4 (HIPK4) inhibits skin epithelial differentiation, but its role in CSCC is unknown.
  • HIPK4 is upregulated in CSCC tissues, suggesting a role in tumorigenesis.

Purpose of the Study:

  • To investigate the role of HIPK4 in CSCC progression.
  • To elucidate the molecular mechanisms by which HIPK4 regulates CSCC.
  • To evaluate HIPK4 as a potential therapeutic target for CSCC.

Main Methods:

  • Co-immunoprecipitation (Co-IP) and GST-pull down assays to analyze protein interactions.
  • Chromatin immunoprecipitation (ChIP) and dual luciferase reporter assays to study gene regulation.
  • In vitro assays for cell proliferation, migration, and invasion; in vivo tumor growth studies in mice.

Main Results:

  • EFEMP1 expression is decreased in CSCC; its overexpression suppresses CSCC cell malignancy.
  • HIPK4 is upregulated in CSCC and its knockdown inhibits tumor growth and malignant behaviors.
  • HIPK4 phosphorylates TAp63, decreasing EFEMP1 expression and promoting CSCC progression.

Conclusions:

  • HIPK4 promotes CSCC progression by inhibiting EFEMP1 through TAp63 phosphorylation.
  • HIPK4 is a potential therapeutic target for cutaneous squamous cell carcinoma.
  • This study provides insights into CSCC molecular mechanisms and therapeutic strategies.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K